Cargando…
MICA enhances sensitivity to cisplatin in patients with extensive small cell lung cancer via downregulation of ABCG2
Immunotherapy utilizing natural killer cell-activated receptor natural-killer group-2 member D ligands (NKG2DLs) has had preclinical success in the treatment of small cell lung cancer. The present study aimed to investigate the association between NKG2Ls and chemoresistance. The mRNA expression of s...
Autores principales: | Wu, Yufeng, Tang, Hong, Si, Ruirui, Xia, Suhua, Wang, Ruilin, Wang, Qiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377106/ https://www.ncbi.nlm.nih.gov/pubmed/32724354 http://dx.doi.org/10.3892/ol.2020.11646 |
Ejemplares similares
-
Depression induces poor prognosis associates with the down-regulation brain derived neurotrophic factor of serum in advanced small cell lung cancer
por: Wu, Yufeng, et al.
Publicado: (2016) -
Emodin enhances cisplatin sensitivity in non-small cell lung cancer through Pgp downregulation
por: Peng, Shuai, et al.
Publicado: (2021) -
Interleukin-7 Resensitizes Non-Small-Cell Lung Cancer to Cisplatin via Inhibition of ABCG2
por: Ke, Bin, et al.
Publicado: (2019) -
The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by
downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer
cells
por: Guo, Jiwei, et al.
Publicado: (2018) -
Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer
por: Xiao, Xiaoguang, et al.
Publicado: (2015)